CATALYST PHARMACEUTICALS INC
CPRXNASDAQ🏆 #1448 by market capEarnings Nov 3US Equity
$31.49▲ $0.00 (+0.00%)
🌙 After hours$31.48▼ 0.03%Regular close · extended-hours price shownTrack CPRX
Get earnings, price moves & breaking news on Telegram
24h▲ 0.0%
7d—
14d—
30d—
ytd▲ 35.0%
1y▲ 50.0%
🏦Market Cap
$3.86B
Small Cap
📈Revenue Growth (YoY)
11.7%
Healthy
📊Gross Margin
86.0%
High
💵FCF Margin
34.9%
Strong
⚖️P/S Ratio
6.5x
Fair
Otter Score
72
Strong
CATALYST PHARMACEUTICALS INC
CPRXAnalyst Ratings
Price
$31.49
Total
16
Raised
1
Lowered
4
Avg PT
$31.75
H / L
$32 / $32
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-05-28 | — | — |
Citigroup | Downgraded | Buy → Neutral | 2026-05-08 | — | — |
Stephens & Co. | Downgraded | Overweight → Equal Weight | 2026-05-07 | — | — |
Baird | Reiterated | Outperform | 2025-03-03 | — | — |
B of A Securities | Reiterated | Buy | 2025-01-09 | — | — |
Truist Securities | Reiterated | Buy | 2024-11-11 | — | — |
Oppenheimer | Reiterated | Outperform | 2024-06-06 | $33.00 | +4.80% |
Cantor Fitzgerald | Reiterated | Overweight | 2024-03-22 | — | — |
Piper Sandler | Reiterated | Overweight | 2022-12-20 | $20.00 | −36.50% |
Roth Capital | Downgraded | Buy → Neutral | 2022-08-24 | $15.50 | −50.80% |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-05-13 | — | — |
PiperJaffray | Reiterated | Overweight | 2018-12-13 | — | — |
MLV & Co. | Reiterated | Buy | 2015-06-24 | — | — |
Maxim Group | Reiterated | Buy | 2013-09-24 | — | — |
Aegis Capital | Reiterated | Buy | 2013-09-06 | — | — |
Rodman & Renshaw | Upgraded | Market Perform → Market Outperform | 2012-08-27 | — | — |
Institution
HC Wainwright & Co.
Downgraded · Buy → Neutral · 2026-05-28
—
—
Citigroup
Downgraded · Buy → Neutral · 2026-05-08
—
—
Stephens & Co.
Downgraded · Overweight → Equal Weight · 2026-05-07
—
—
Baird
Reiterated · Outperform · 2025-03-03
—
—
B of A Securities
Reiterated · Buy · 2025-01-09
—
—
Truist Securities
Reiterated · Buy · 2024-11-11
—
—
Oppenheimer
Reiterated · Outperform · 2024-06-06
$33.00
+4.80%
Cantor Fitzgerald
Reiterated · Overweight · 2024-03-22
—
—
Piper Sandler
Reiterated · Overweight · 2022-12-20
$20.00
−36.50%
Roth Capital
Downgraded · Buy → Neutral · 2022-08-24
$15.50
−50.80%
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-05-13
—
—
PiperJaffray
Reiterated · Overweight · 2018-12-13
—
—
MLV & Co.
Reiterated · Buy · 2015-06-24
—
—
Maxim Group
Reiterated · Buy · 2013-09-24
—
—
Aegis Capital
Reiterated · Buy · 2013-09-06
—
—
Rodman & Renshaw
Upgraded · Market Perform → Market Outperform · 2012-08-27
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space